Cargando…

COVID-19’s natural course among ambulatory monitored outpatients

Research objective was to detail COVID-19’s natural trajectory in relation to the Czech population’s viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19’s impact among 105 outpatients. In accordance with government quarantine requirements, outpatien...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinbergerova, Barbora, Mayer, Jiri, Hrabovsky, Stepan, Novakova, Zuzana, Pospisil, Zdenek, Martykanova, Lucie, Hortova, Katerina, Mandelova, Lucie, Hejduk, Karel, Chloupková, Renata, Pospisil, Michal, Doubkova, Martina, Marek, Vladimir, Novotna, Renata, Dolecek, Martin, Kubesova, Hana Matejovska, Brat, Kristian, Parizkova, Radana, Husa, Petr, Mechl, Marek, Kral, Zdenek, Lengerova, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115337/
https://www.ncbi.nlm.nih.gov/pubmed/33980931
http://dx.doi.org/10.1038/s41598-021-89545-1
_version_ 1783691209865166848
author Weinbergerova, Barbora
Mayer, Jiri
Hrabovsky, Stepan
Novakova, Zuzana
Pospisil, Zdenek
Martykanova, Lucie
Hortova, Katerina
Mandelova, Lucie
Hejduk, Karel
Chloupková, Renata
Pospisil, Michal
Doubkova, Martina
Marek, Vladimir
Novotna, Renata
Dolecek, Martin
Kubesova, Hana Matejovska
Brat, Kristian
Parizkova, Radana
Husa, Petr
Mechl, Marek
Kral, Zdenek
Lengerova, Martina
author_facet Weinbergerova, Barbora
Mayer, Jiri
Hrabovsky, Stepan
Novakova, Zuzana
Pospisil, Zdenek
Martykanova, Lucie
Hortova, Katerina
Mandelova, Lucie
Hejduk, Karel
Chloupková, Renata
Pospisil, Michal
Doubkova, Martina
Marek, Vladimir
Novotna, Renata
Dolecek, Martin
Kubesova, Hana Matejovska
Brat, Kristian
Parizkova, Radana
Husa, Petr
Mechl, Marek
Kral, Zdenek
Lengerova, Martina
author_sort Weinbergerova, Barbora
collection PubMed
description Research objective was to detail COVID-19’s natural trajectory in relation to the Czech population’s viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19’s impact among 105 outpatients. In accordance with government quarantine requirements, outpatients were divided into a cohort with two negative tests at the end of the disease (40 patients) and a cohort with a new algorithm (65 patients) following a 14-day quarantine. Median follow-up differed significantly between the 2 groups (23 days vs. 16 days). Only 6% of patients were asymptomatic during the entire telemonitoring period. Another 13% of patients were diagnosed asymptomatic, as suspected contacts, yet later developed symptoms, while the remaining 81% were diagnosed as symptomatic on average 6 days following symptom onset. Telemonitoring enabled precise symptom status chronicling. The most frequently reported complaints were fevers, respiratory issues, and anosmia. Six patients were eventually hospitalized for complications detected early after routine telemonitoring. During the extended follow-up (median 181 days), anosmia persisted in 26% of patients. 79% of patients in the new quarantine algorithm cohort reported no symptoms on day 11 compared to just 56% of patients in the two negative test cohort upon first testing negative (median–19 days). The highest viral load occurred within 0–2 days of initial symptom onset. Both the PCR viral load and two consecutive PCR negative sample realizations indicated high interindividual variability with a surprisingly fluctuating pattern among 43% of patients. No definitive COVID-19 symptoms or set of symptoms excepting anosmia (59%) and/or ageusia (47%) were identified. No preexisting medical conditions specifically foreshadowed disease trajectory in a given patient. Without a PCR negativity requirement for quarantine cessation, patients could exhibit fewer symptoms. Our study therefore highlights the urgent need for routine ambulatory patient telemedicine monitoring, early complication detection, intensive mass education connecting disease demeanor with subsequent swift diagnostics, and, notably, the need to reevaluate and modify quarantine regulations for better control of SARS-CoV-2 proliferation.
format Online
Article
Text
id pubmed-8115337
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81153372021-05-14 COVID-19’s natural course among ambulatory monitored outpatients Weinbergerova, Barbora Mayer, Jiri Hrabovsky, Stepan Novakova, Zuzana Pospisil, Zdenek Martykanova, Lucie Hortova, Katerina Mandelova, Lucie Hejduk, Karel Chloupková, Renata Pospisil, Michal Doubkova, Martina Marek, Vladimir Novotna, Renata Dolecek, Martin Kubesova, Hana Matejovska Brat, Kristian Parizkova, Radana Husa, Petr Mechl, Marek Kral, Zdenek Lengerova, Martina Sci Rep Article Research objective was to detail COVID-19’s natural trajectory in relation to the Czech population’s viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19’s impact among 105 outpatients. In accordance with government quarantine requirements, outpatients were divided into a cohort with two negative tests at the end of the disease (40 patients) and a cohort with a new algorithm (65 patients) following a 14-day quarantine. Median follow-up differed significantly between the 2 groups (23 days vs. 16 days). Only 6% of patients were asymptomatic during the entire telemonitoring period. Another 13% of patients were diagnosed asymptomatic, as suspected contacts, yet later developed symptoms, while the remaining 81% were diagnosed as symptomatic on average 6 days following symptom onset. Telemonitoring enabled precise symptom status chronicling. The most frequently reported complaints were fevers, respiratory issues, and anosmia. Six patients were eventually hospitalized for complications detected early after routine telemonitoring. During the extended follow-up (median 181 days), anosmia persisted in 26% of patients. 79% of patients in the new quarantine algorithm cohort reported no symptoms on day 11 compared to just 56% of patients in the two negative test cohort upon first testing negative (median–19 days). The highest viral load occurred within 0–2 days of initial symptom onset. Both the PCR viral load and two consecutive PCR negative sample realizations indicated high interindividual variability with a surprisingly fluctuating pattern among 43% of patients. No definitive COVID-19 symptoms or set of symptoms excepting anosmia (59%) and/or ageusia (47%) were identified. No preexisting medical conditions specifically foreshadowed disease trajectory in a given patient. Without a PCR negativity requirement for quarantine cessation, patients could exhibit fewer symptoms. Our study therefore highlights the urgent need for routine ambulatory patient telemedicine monitoring, early complication detection, intensive mass education connecting disease demeanor with subsequent swift diagnostics, and, notably, the need to reevaluate and modify quarantine regulations for better control of SARS-CoV-2 proliferation. Nature Publishing Group UK 2021-05-12 /pmc/articles/PMC8115337/ /pubmed/33980931 http://dx.doi.org/10.1038/s41598-021-89545-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Weinbergerova, Barbora
Mayer, Jiri
Hrabovsky, Stepan
Novakova, Zuzana
Pospisil, Zdenek
Martykanova, Lucie
Hortova, Katerina
Mandelova, Lucie
Hejduk, Karel
Chloupková, Renata
Pospisil, Michal
Doubkova, Martina
Marek, Vladimir
Novotna, Renata
Dolecek, Martin
Kubesova, Hana Matejovska
Brat, Kristian
Parizkova, Radana
Husa, Petr
Mechl, Marek
Kral, Zdenek
Lengerova, Martina
COVID-19’s natural course among ambulatory monitored outpatients
title COVID-19’s natural course among ambulatory monitored outpatients
title_full COVID-19’s natural course among ambulatory monitored outpatients
title_fullStr COVID-19’s natural course among ambulatory monitored outpatients
title_full_unstemmed COVID-19’s natural course among ambulatory monitored outpatients
title_short COVID-19’s natural course among ambulatory monitored outpatients
title_sort covid-19’s natural course among ambulatory monitored outpatients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115337/
https://www.ncbi.nlm.nih.gov/pubmed/33980931
http://dx.doi.org/10.1038/s41598-021-89545-1
work_keys_str_mv AT weinbergerovabarbora covid19snaturalcourseamongambulatorymonitoredoutpatients
AT mayerjiri covid19snaturalcourseamongambulatorymonitoredoutpatients
AT hrabovskystepan covid19snaturalcourseamongambulatorymonitoredoutpatients
AT novakovazuzana covid19snaturalcourseamongambulatorymonitoredoutpatients
AT pospisilzdenek covid19snaturalcourseamongambulatorymonitoredoutpatients
AT martykanovalucie covid19snaturalcourseamongambulatorymonitoredoutpatients
AT hortovakaterina covid19snaturalcourseamongambulatorymonitoredoutpatients
AT mandelovalucie covid19snaturalcourseamongambulatorymonitoredoutpatients
AT hejdukkarel covid19snaturalcourseamongambulatorymonitoredoutpatients
AT chloupkovarenata covid19snaturalcourseamongambulatorymonitoredoutpatients
AT pospisilmichal covid19snaturalcourseamongambulatorymonitoredoutpatients
AT doubkovamartina covid19snaturalcourseamongambulatorymonitoredoutpatients
AT marekvladimir covid19snaturalcourseamongambulatorymonitoredoutpatients
AT novotnarenata covid19snaturalcourseamongambulatorymonitoredoutpatients
AT dolecekmartin covid19snaturalcourseamongambulatorymonitoredoutpatients
AT kubesovahanamatejovska covid19snaturalcourseamongambulatorymonitoredoutpatients
AT bratkristian covid19snaturalcourseamongambulatorymonitoredoutpatients
AT parizkovaradana covid19snaturalcourseamongambulatorymonitoredoutpatients
AT husapetr covid19snaturalcourseamongambulatorymonitoredoutpatients
AT mechlmarek covid19snaturalcourseamongambulatorymonitoredoutpatients
AT kralzdenek covid19snaturalcourseamongambulatorymonitoredoutpatients
AT lengerovamartina covid19snaturalcourseamongambulatorymonitoredoutpatients